| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0038 | 1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.0081 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0017 | 1 |